Exact Sciences files Form 15 to terminate 12(g) registration

Exact Sciences Corporation filed a Form 15 to terminate registration under Section 12(g) and suspend certain reporting obligations.

Rhea-AI Filing Summary

Exact Sciences Corporation filed a Form 15 to terminate registration under Section 12(g) and suspend certain reporting obligations. The company lists Common Stock, $0.01 par value per share and two convertible note series among covered classes. The filing is dated April 2, 2026.

Key Figures

Form date: April 2, 2026 Common stock par value: $0.01 per share 0.3750% Notes due 2027: Less than 300 (units) +1 more

4 metrics

Form date April 2, 2026 Signature date on the Form 15

Common stock par value $0.01 per share Listed class on the Form 15

0.3750% Notes due 2027 Less than 300 (units) Quantity reported in filing excerpt

0.3750% Notes due 2028 Less than 300 (units) Quantity reported in filing excerpt

Key Terms

Form 15, Section 12(g), Sections 13 and 15(d)

3 terms

Form 15 regulatory

"FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION"

A Form 15 is a short filing a public company uses with the U.S. Securities and Exchange Commission to stop or pause its routine public reporting requirements when it meets certain legal thresholds (such as a low number of public shareholders) or other qualifying conditions. Investors should care because filing one typically means less public financial information and lower trading liquidity—similar to a shop taking down its public notice board, making it harder to track performance and buy or sell shares.

Section 12(g) regulatory

"TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT"

Section 12(g) is a rule that requires companies to register with the government and share their financial details when they have a certain number of shareholders or assets. It matters because it makes these companies more transparent, helping investors make informed decisions and keeping the markets fair.

Sections 13 and 15(d) regulatory

"SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Exact Sciences (EXAS) Form 15 filing mean?

It notifies the SEC of termination of registration/suspension of certain reporting duties. The filing states the company is terminating registration under Section 12(g) and/or suspending duties under Sections 13 and 15(d). The effective mechanics and timing are not detailed in the excerpt.

Which securities are listed on Exact Sciences' Form 15?

The filing lists Common Stock ($0.01 par) and two convertible note series. It also shows Preferred Stock, Debt Securities, Warrants, and Rights listed with zero balances in the excerpt.

Are the 0.3750% Convertible Senior Notes due 2027 and 2028 still outstanding?

The excerpt indicates each convertible note series is reported as "Less than 300" in the filing. No further detail on holders, principal outstanding, or conversion status is provided in the excerpt.

When was the Form 15 signed for Exact Sciences (EXAS)?

The signature block shows the Form 15 was signed on April 2, 2026. The filing is executed by James R. Wenner, Vice President and Treasurer, representing Exact Sciences Corporation.

Does this Form 15 mean Exact Sciences will stop filing all SEC reports?

Not necessarily; Form 15 indicates termination of registration under Section 12(g) or suspension of duties under Sections 13 and 15(d). The excerpt lists remaining classes as "None," but it does not describe broader reporting strategy or exceptions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 06:06 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-35092

Exact Sciences Corporation

(Exact name of registrant as specified in its charter)

Exact Sciences Corporation

5505 Endeavor Lane

Madison, WI 53719

Tel: (608) 284-5700

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.01 par value per share

0.3750% Convertible Senior Notes due 2027

0.3750% Convertible Senior Notes due 2028

Preferred Stock*

Debt Securities*

Warrants*

Rights*

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)		☒
Rule 12g-4(a)(2)		☐
Rule 12h-3(b)(1)(i)		☒
Rule 12h-3(b)(1)(ii)		☐
Rule 15d-6		☒
Rule 15d-22(b)		☐

Approximate number of holders of record as of the certification or notice date:

Common Stock, $0.01 par value per share: 1

0.3750% Convertible Senior Notes due 2027: Less than 300

0.3750% Convertible Senior Notes due 2028: Less than 300

Preferred Stock, Debt Securities, Warrants, Rights: 0

* Unissued securities registered under automatic shelf registration statement on Form S-3 (File No. 333-272196)

Pursuant to the requirements of the Securities Exchange Act of 1934, Exact Sciences Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: April 2, 2026				Exact Sciences Corporation
				By:		/s/ James R. Wenner
				Name:		James R. Wenner
				Title:		Vice President and Treasurer